Estimating the benefits of reduced fracture incidence for patients living with osteogenesis imperfecta and for healthcare payers
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Conference item |
| Sprache: | English |
| Veröffentlicht: |
International Society for Pharmacoeconomics and Outcomes Research
2024
|